Angela J Henderson

Title: Angela J Henderson: Innovator in Cancer Treatment

Introduction

Angela J Henderson is a prominent inventor based in Fort Collins, Colorado. She has made significant contributions to the field of cancer treatment through her innovative research and development of myeloid derived suppressor cell (MDSC) inhibitory agents. Her work aims to enhance the efficacy of cancer vaccines and improve treatment regimens for patients.

Latest Patents

Angela holds 1 patent for her invention titled "Myeloid derived suppressor cell inhibiting agents." This patent includes the development of MDSC inhibitory agents and vaccine and/or adjuvant enhancers. The invention presents improved vaccine treatment regimens that utilize these agents, along with methods for inhibiting tumor growth and cancer metastases. The MDSC inhibiting agents described in her patent include bisphosphonates, such as liposomal clodronate, and CCR2 inhibitors and/or antagonists. Additionally, her patent outlines methods for enhancing antibody titer levels in response to specific antigens.

Career Highlights

Angela is affiliated with the Colorado State University Research Foundation, where she conducts her research. Her work has garnered attention for its potential to revolutionize cancer treatment and improve patient outcomes.

Collaborations

Angela has collaborated with notable colleagues, including Steven Dow and Leah Mitchell, to advance her research and develop innovative solutions in cancer therapy.

Conclusion

Angela J Henderson is a dedicated inventor whose work in developing MDSC inhibitory agents is paving the way for more effective cancer treatments. Her contributions to the field are invaluable and hold promise for future advancements in cancer therapy.